News Update: Jazz Pharmaceuticals Jumps 10% on Fibromyalgia Drug Results (JAZZ)
News Update: Jazz Pharmaceuticals Jumps 10% On Fibromyalgia Drug Results (JAZZ) – Jazz Pharmaceuticals (NASDAQ:JAZZ) shares rose 9.7% at the open after the FDA said its drug candidate JZP-6 was found to be affective in the treatment of fib…